 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, February 15, 1999, 19(4):1416-1423
GDNF Protection against 6-OHDA-Induced Reductions in Potassium-Evoked Overflow of Striatal Dopamine
Wayne A. Cass and Michael W. Manning Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, Lexington, Kentucky 40536-0298
Glial cell line-derived neurotrophic factor (GDNF), when administered before 6-hydroxydopamine (6-OHDA), has been shown to prevent the reduction in nigral dopamine (DA) levels and tyrosine hydroxylase-positive neurons normally observed after 6-OHDA lesions. The present study examined the ability of GDNF to prevent 6-OHDA-induced reductions in striatal DA release and reductions in striatal and nigral DA levels. GDNF (10 µg), or vehicle, was injected into the right nigra of anesthetized male Fischer-344 rats and was followed 6 hr later by intranigral 6-OHDA or saline. Three to four weeks later the animals were anesthetized with urethane and prepared for in vivo electrochemistry. Potassium-evoked overflow of DA was dramatically decreased in the right striatum of the vehicle + 6-OHDA-treated animals. GDNF appeared to prevent the reduction in evoked overflow of DA in the right striatum of the 6-OHDA-treated animals. However, in comparison with that in animals that received GDNF + saline, the overflow of DA was significantly reduced in the GDNF + 6-OHDA animals. Similarly, although nigral levels of DA were above normal in the GDNF + 6-OHDA-treated animals, they were below DA levels found in GDNF + saline-treated rats. Striatal DA levels were partially protected by GDNF. In animals examined 10-12 weeks after the GDNF and 6-OHDA treatments, the apparent protective ability of GDNF on the evoked overflow of DA in the striatum was diminished. Thus, although intranigral GDNF can prevent 6-OHDA-induced reductions in nigral DA levels, long-term protection of the evoked overflow of DA in the striatum is minimal.
Key words: GDNF; 6-hydroxydopamine; striatum; dopamine; neurotrophic factor; in vivo electrochemistry; neurotoxicity
Copyright © 1999 Society for Neuroscience 0270-6474/99/1941416-08$05.00/0
This article has been cited by other articles:
H. A. Boger, L. D. Middaugh, K. S. Patrick, S. Ramamoorthy, E. D. Denehy, H. Zhu, A. M. Pacchioni, A.-C. Granholm, and J. F. McGinty
Long-Term Consequences of Methamphetamine Exposure in Young Adults Are Exacerbated in Glial Cell Line-Derived Neurotrophic Factor Heterozygous Mice
J. Neurosci., August 15, 2007; 27(33): 8816 - 8825.
[Abstract] [Full Text] [PDF]
W. A CASS, M. P SMITH, and L. E PETERS
Calcitriol Protects against the Dopamine- and Serotonin-Depleting Effects of Neurotoxic Doses of Methamphetamine.
Ann. N.Y. Acad. Sci., August 1, 2006; 1074: 261 - 271.
[Abstract] [Full Text] [PDF]
W. A CASS, L. E PETERS, M. E HARNED, and K. B SEROOGY
Protection by GDNF and Other Trophic Factors Against the Dopamine-Depleting Effects of Neurotoxic Doses of Methamphetamine.
Ann. N.Y. Acad. Sci., August 1, 2006; 1074: 272 - 281.
[Abstract] [Full Text] [PDF]
W. A. CASS, M. W. MANNING, and S. L. BAILEY
Restorative Effects of GDNF on Striatal Dopamine Release in Rats Treated with Neurotoxic Doses of Methamphetamine
Ann. N.Y. Acad. Sci., September 1, 2000; 914(1): 127 - 136.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|